Vitro Biopharma, Inc. Quarterly Deferred Tax Assets, Gross in USD from Q3 2012 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Vitro Biopharma, Inc. quarterly Deferred Tax Assets, Gross history and growth rate from Q3 2012 to Q3 2023.
  • Vitro Biopharma, Inc. Deferred Tax Assets, Gross for the quarter ending October 31, 2023 was $5.05M, a 36.2% increase year-over-year.
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $5.05M +$1.34M +36.2% Oct 31, 2023 10-K 2024-01-29
Q3 2022 $3.71M Oct 31, 2022 10-K 2024-01-29
Q3 2015 $1.26M +$82.2K +7% Oct 31, 2015 10-K 2016-09-22
Q3 2014 $1.17M -$894K -43.2% Oct 31, 2014 10-K 2016-09-22
Q3 2013 $2.07M +$49.6K +2.45% Oct 31, 2013 10-Q 2016-03-30
Q3 2012 $2.02M Oct 31, 2012 10-Q 2014-09-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.